DK0639224T3 - Varianter i lectindomænet af selectin - Google Patents

Varianter i lectindomænet af selectin

Info

Publication number
DK0639224T3
DK0639224T3 DK93910869T DK93910869T DK0639224T3 DK 0639224 T3 DK0639224 T3 DK 0639224T3 DK 93910869 T DK93910869 T DK 93910869T DK 93910869 T DK93910869 T DK 93910869T DK 0639224 T3 DK0639224 T3 DK 0639224T3
Authority
DK
Denmark
Prior art keywords
selectin
variants
lectin domain
amino acid
nucleotide sequences
Prior art date
Application number
DK93910869T
Other languages
English (en)
Inventor
Laurence A Lasky
David V Erbe
Leonard G Presta
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DK0639224T3 publication Critical patent/DK0639224T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564Selectins, e.g. CD62
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/30Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/32Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Non-Volatile Memory (AREA)
  • Semiconductor Memories (AREA)
DK93910869T 1992-04-30 1993-04-28 Varianter i lectindomænet af selectin DK0639224T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87903692A 1992-04-30 1992-04-30
US95670192A 1992-10-01 1992-10-01
PCT/US1993/003987 WO1993022436A1 (en) 1992-04-30 1993-04-28 Lectin domain variants of selectin

Publications (1)

Publication Number Publication Date
DK0639224T3 true DK0639224T3 (da) 2000-10-30

Family

ID=27128518

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93910869T DK0639224T3 (da) 1992-04-30 1993-04-28 Varianter i lectindomænet af selectin

Country Status (12)

Country Link
US (1) US5593882A (da)
EP (1) EP0639224B1 (da)
JP (2) JPH07506253A (da)
AT (1) ATE194168T1 (da)
AU (1) AU674317B2 (da)
CA (1) CA2134756C (da)
DE (1) DE69328928T2 (da)
DK (1) DK0639224T3 (da)
ES (1) ES2152251T3 (da)
GR (1) GR3034447T3 (da)
PT (1) PT639224E (da)
WO (1) WO1993022436A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186455A1 (en) * 1994-03-29 1995-10-05 Raymond John Owens Antibodies against e-selectin
US6127524A (en) * 1996-10-18 2000-10-03 Dade Behring Inc. Binding molecules and computer-based methods of increasing the binding affinity thereof
EP1282425A4 (en) * 2000-05-19 2004-09-15 Inst Genetics Llc P-SELECTIN CRYSTAL STRUCTURE, P- AND E-SELECTIN COMPLEXES, AND USE THEREOF
EP1842551A1 (en) * 2000-05-24 2007-10-10 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services E-selectin for treating or preventing stroke
US7897575B2 (en) * 2000-05-24 2011-03-01 The United States Of America As Represented By The Department Of Health And Human Services Treatment and prevention of vascular dementia
EP2284270A3 (en) 2000-12-13 2012-07-25 Anaphore, Inc. Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
ATE431851T1 (de) 2000-12-13 2009-06-15 Anaphore Inc Methode zur identifikation und isolation von peptide die andere moleküle binden aus kombinatorische proteinbibliotheken mit einer c- typ lectin-ähnlichen domäne als gerüststruktur
JP3658394B2 (ja) * 2001-02-20 2005-06-08 サミット・グライコリサーチ株式会社 糖鎖解析用レクチン群及びその使用方法
US20040116333A1 (en) * 2001-08-03 2004-06-17 Rong-Hwa Lin Modulators of P-selectin glycoprotein ligand 1
WO2003054164A2 (en) 2001-12-19 2003-07-03 Immunex Corporation C-type lectin polypeptide, polynucleotide and methods of making and use thereof
US20070244043A1 (en) * 2005-03-10 2007-10-18 Novavax, Inc. Recombinant E-selectin made in insect cells
HUE041957T2 (hu) 2006-12-01 2019-06-28 Novartis Ag Anti-P-szelektin antitestek és eljárások azok alkalmazására gyulladásos betegségek kezelésére
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
JP2010538655A (ja) * 2007-09-12 2010-12-16 アナフォア インコーポレイテッド 自己免疫疾患についてのhsp70に基づく治療
US20110086806A1 (en) * 2009-10-09 2011-04-14 Anaphore, Inc. Polypeptides that Bind IL-23R
JP2013507124A (ja) * 2009-10-09 2013-03-04 アナフォア インコーポレイテッド Il−23rを結合するポリペプチド
AU2011349124B2 (en) * 2010-12-21 2016-09-15 Oklahoma Medical Research Foundation Anti-P-selectin antibodies and methods of their use and identification
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
AU2018244030B2 (en) * 2017-03-29 2021-10-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Purification of an agent of interest
CN121108302A (zh) * 2025-09-22 2025-12-12 渼达(广州)生物科技有限公司 一种重组人Fc和P-选择素的重组蛋白、检测产品及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081034A (en) * 1988-11-14 1992-01-14 Brigham & Women's Hospital Cloned genes which encode elam-1
US5098833A (en) * 1989-02-23 1992-03-24 Genentech, Inc. DNA sequence encoding a functional domain of a lymphocyte homing receptor
ATE224911T1 (de) * 1990-07-17 2002-10-15 Univ Oklahoma Gmp-140 ligand

Also Published As

Publication number Publication date
GR3034447T3 (en) 2000-12-29
EP0639224A1 (en) 1995-02-22
CA2134756A1 (en) 1993-11-11
EP0639224B1 (en) 2000-06-28
JP2004049234A (ja) 2004-02-19
JP3749529B2 (ja) 2006-03-01
PT639224E (pt) 2000-12-29
ES2152251T3 (es) 2001-02-01
AU674317B2 (en) 1996-12-19
ATE194168T1 (de) 2000-07-15
AU4220893A (en) 1993-11-29
DE69328928T2 (de) 2000-11-30
CA2134756C (en) 2010-04-20
JPH07506253A (ja) 1995-07-13
DE69328928D1 (de) 2000-08-03
US5593882A (en) 1997-01-14
WO1993022436A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
DE69328928D1 (de) Varianten in den leltin domäne von selektin
DE69232537D1 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
DK0640135T3 (da) Immunoglobulinbindende proteiner, der er afledt af protein L, og anvendelser af disse
TR199900267T2 (xx) GnRH-L�kotoksin kimeralar�.
DE69433406T2 (de) Antikörper gegen cd40
FI20010060A7 (fi) 5-metoksi-indoli-3-karboksialdehydiamino-(pentyyliamino)metyleeni-hydratsoni
DK0783366T3 (da) Kromatografiske harpikser og fremgangsmåder til anvendelse af samme
DK0710228T3 (da) Hydraziner med N3S-konfiguration som radionuclidchelatorer
DK3184545T3 (da) Antagonistiske selektive bindingsmidler af osteoprotegerin-bindingsprotein
BR0011849A (pt) Anticorpos enxertados lm609 melhorados
PT726955E (pt) Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes
DK296189A (da) Nucleinsyresekvenser, som koder for peptidsekvenser af carcinoembryonisk antigen-familien
DE69434384D1 (de) Metalkomplexbildner
ATE473292T1 (de) Sicherheitssystem
DK1017715T3 (da) Kimært polypeptid der omfatter fragment B af shiga-toksin og peptider af terapeutisk interesse
AU8855498A (en) Device for linking reinforced concrete elements
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
DK0610260T3 (da) Vacciner mod Actinobacillus pleuropneumoniae
DE60127113D1 (de) Gd3 mimetische peptide
DE69224134D1 (de) Monoklonale Antikörper gegen Hepatitis-C-Virus
PT915970E (pt) Lectinas de tipo c
IL156041A0 (en) Nucleic acid adjuvants
DE69619808D1 (de) Chimäre msp und daf proteine mit einem telloberflächenlokalisierendem domän
NO962827L (no) Monoklonale antistoffer mot antigener uttrykt av hematopoietider facilitatoriske celler
DE602006014140D1 (de) Mit scytovirin der domäne 1 verwandte polypeptide